April 5, 2023 NIH Refuses to Employ “March-In” Rights in Petition to Lower Cancer Drug Costs By Olivia Santiago
April 29, 2022 Where We Are Now on the COVID-19 TRIPS Proposal—Is an IP Waiver the Right Way to Address Vaccine Inequity? By Kelsey Price
April 11, 2022 Fair Enough Says SCOTUS: The High Court Keeps Assignor Estoppel on Life Support but May as Well Have Pulled the Plug By Mark Brodt
December 11, 2021 Patent Subject Matter Eligibility in the Biotechnology Industry By Mikaella Evaristo
December 11, 2021 Can Moral Utility Deter American Tech’s Complicity in Human Rights Abuses? By Kevin Ruane
December 11, 2021 Are Digital Inventors Real? Issues with Artificial Intelligence and Patent Invention By Odeya de la Mure